Global Diabetes Diagnostics Industryhttp://www.reportlinker.com/p092478/Global-Diabetes-Diagnostics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_
Advertisement
This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Million by the following Product Segments: Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, & Diabetes Tracking System), and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, & Others (Include Blood Glucose Sensors, Control Solution, and Reagent Tablets). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Abbott Diabetes Care, Bayer Diabetes Care, Bio-Rad Laboratories, Nipro Diagnostics, Inc., LifeScan, Inc., Medtronic MiniMed, Inc., Roche Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Advertisement
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Blood Glucose Testing Devices I-4Blood Glucose Monitor I-4Diabetes Kit I-4Diabetes Tracking System I-4Blood Glucose Sensor I-4Diabetes Testing Supplies I-4Blood Glucose Test Strips I-4Lancet I-5Lancet Device I-5Reagent Strips I-5
II. EXECUTIVE SUMMARY
1. MARKET OUTLOOK II-1Increasing Diabetes Prevalence - A Major Growth Propeller II-1Table 1: Worldwide Diabetes Market (2000 & 2025): PercentageBreakdown of Diabetes Incidence by Region - India, China,Brazil, Russia and Others (includes correspondingGraph/Chart) II-1Diabetics Cut Back Spending on Disease Management duringRecession, Market Recovers from 2010 II-2
2. MARKET DYNAMICS AND TRENDS II-3Major Pharma Players - Focusing on Diabetes Diagnostics II-3Growing Emphasis on Technological Integration in Diabetes Market II-3Outlook Bright for Blood Glucose Meters and Strips II-3Self Monitoring of Blood Glucose on the Rise II-4Trends in the Glucose Meter/Monitoring Systems II-4Focus on Established Procedures Driving Growth II-4Portable Glucose Meters Fast Replacing Conventional TestingMethods II-4Point-of-Care Testing - A Profitable Venture II-5It Pays to be Customer Focused in a Mature Market II-5Advancements in Glucose Monitoring Devices - A New Ray of Hope II-5Pain-Free and Alternate-Site Glucose Monitoring II-5Continuous Glucose Monitoring II-6Up-to-the-Minute Monitoring II-6Medicare Coverage - A Strong Positive II-6
3. COMPETITION II-7Self-Monitoring/Household Blood Glucose - Spearheading Growth II-7Table 2: Global Household Blood Glucose Monitoring DeviceMarket (2011): Percentage Market Share Breakdown by LeadingPlayers (includes corresponding Graph/Chart) II-7
4. TRENDS IN DIABETES MANAGEMENT II-8Recent Advancements in Diabetes Management II-8New Developments II-8Recent Advancements in Diabetes Therapy II-8Aldose Reductase Inhibitors (ARI) II-8Advanced Glycation End-Product Inhibitors (AGEI) II-8Rising Awareness of Diabetes II-9Insulin Delivery Systems - A Potential High Growth Segment II-9Innovations in Insulin Delivery II-9Advances in Insulin Delivery - A Review II-10Pulmonary Insulin Delivery II-10Jet Injection II-11Ultrasonic Transdermal-Patch Technology II-11Insulin Delivery via Mouth Spray II-11Artificial Pancreas Technology II-11Increased Incidence of Diabetes Among HIV+ II-12
5. TECHNOLOGICAL TRENDS II-14Innovative Product Design Developments Enhance Diabetic'sQuality of Life II-14Reducing Costs for Managed Care Service Providers - EmergingTrend II-14Finding Solutions Through Innovations II-14
6. BLOODLESS TESTING - AN OVERVIEW II-16Non-invasive Blood Glucose Testing - Still in Experimental Stage II-16High Price - A Major Hurdle II-16
7. A PEEK INTO OTC/PHYSICIANS' OFFICE DIABETES TESTS MARKET II-17In-home Tests: Making Health Control Easier II-17Common OTC Tests II-17Glucose Monitor II-17Cholesterol II-17Major Market Segments in OTC/Physicians' Office Diabetes Tests II-17Urine Strips II-18Blood Glucose Strips: A Well Established Market II-18Blood Glucose Meters II-19PBGM Devices: Based on Photometric or Biosensor Technology II-20
8. LABORATORY DIABETES TESTS MARKET - A PRIMER II-21Various Types of Laboratory Diabetes Tests II-21Blood Glucose & Related Tests II-21Fructosamine Tests: To Diagnose Gestational Diabetes II-21Glycosylated Hemoglobin Tests: A Promising Approach inDiagnosing Diabetes Mellitus II-21Glycosylated Haemoglobin Tests - Paving Way for Early StageDiabetes Diagnosis II-22Immunoassays (Anti-Insulin and Anti-Islet Antibodies) II-22It Pays to Introduce Advanced Instruments II-22Urine Ketones and Microalbuminuria: To Test Type I Diabetes II-23Diabetic Renal Disease with Reference to Microalbuminuria II-23All Other Diabetes Tests II-23Diabetes Tests II-23Fasting Plasma Glucose Test II-23Casual Glucose Test II-23
9. DIABETES DIAGNOSTICS - AN OVERVIEW II-24Cost - The Ultimate Factor in the Choice of Blood GlucoseMonitoring Systems II-24Classification II-24Blood Glucose Testing Devices II-25Blood Glucose Monitor/Meter II-25Select Blood Glucose Meters Based on Test Strips II-25Diabetes Kit II-26Diabetes Tracking System II-26Blood Glucose Sensor II-26Diabetes Testing Supplies II-26Blood Glucose Test Strips II-26Lancet II-26Lancet Device II-26Reagent Strips II-27Reagent Tablet II-27
10. DIABETES: A CHRONIC BODY DISORDER II-28Diabetes Symptoms II-28Diabetes: One of the Leading Causes of Death in DevelopedCountries II-28Types of Diabetes II-29Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM) II-29Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM) II-30NIDDM Might Lead to Cardiovascular Complications II-30Increasing Occurrence of Type II Diabetes Worldwide II-30Factors Influencing Type 2 diabetes II-31Agents Used for Type 2 Diabetes Treatment II-31Diabetes: A Major Healthcare Challenge II-31Etiological Factors Causing Diabetes II-32Insulin Types II-32Diabetes-Related Complications II-32Complications Associated with Diabetes - In a Nutshell II-33Heart Disease II-33Stroke II-34High Blood Pressure II-34Blindness II-34Kidney Disease II-34Nerve Disease II-34Amputations II-34Dental Disease II-34Pregnancy II-34Possible Complications of Diabetes II-34Microvascular Complications (Small Blood Vessel Damage) II-34Macrovascular Complications (Large Blood Vessel Damage) II-35Other Complications II-35Microvascular Complications (Small Blood Vessel Damage) II-35Retinopathy II-35Diabetic Neuropathy II-35Nephropathy II-35Macrovascular Complications (Large Blood Vessel Damage) II-36Cardiac Problems II-36Hypertension (High Blood Pressure) II-36Other Major Complications II-36Infections II-36Impotence II-36Pregnancy Complications II-36Other Complications Resulting from Diabetes II-36Obesity II-36Obsessive Compulsive Disorder II-37Foot Ulcers II-37Dementia and its Association with Diabetes II-37Hypoglycemia II-37Diabetic Ketoacidosis II-38Undiagnosed Diabetics: More Prone to Cardiovascular Diseases II-39
11. DIABETES INCIDENCE AND PREVALENCE II-40Table 3: Worldwide Prevalence of Diabetes Mellitus by Region:2010 & 2030 (includes corresponding Graph/Chart) II-40Diabetes Mellitus Cases Worldwide - A Demographic Analysis byGeographic Region II-41North America II-41United States II-41Canada II-41Mexico II-41Table 4: Prevalence of Diabetes Mellitus in North America(2010 & 2030): Breakdown by Country, Age Group, and Gender(In Thousand People & %) (includes correspondingGraph/Chart) II-41Europe II-42Table 5: Prevalence of Diabetes Mellitus in Europe (2010 &2030): Breakdown by Country, Age Group, and Gender (InThousand People & %) II-42Asia-Pacific II-43Southeast Asian Region II-43Western Pacific Region II-43Table 6: Prevalence of Diabetes Mellitus in South East Asia(2010 & 2030): Breakdown by Country, Age Group, and Gender(In Thousand People & %) (includes correspondingGraph/Chart) II-44Table 7: Prevalence of Diabetes Mellitus in Western Asia(2010 & 2030): Breakdown by Country, Age Group, and Gender(In Thousand People & %) (includes correspondingGraph/Chart) II-45South & Central America II-46Type-1 Diabetes II-46Type-2 Diabetes II-46Table 8: Prevalence of Diabetes Mellitus in South & CentralAmerica (2010 & 2030): Breakdown by Country, Age Group, andGender (In Thousand People & % II-47Rest of World II-48Table 9: Prevalence of Diabetes Mellitus in Africa (2010 &2030): Breakdown by Country, Age Group, and Gender (InThousand People & %) II-48Table 10: Prevalence of Diabetes Mellitus in The Middle East& North Africa (2010 & 2030): Breakdown by Country, AgeGroup, and Gender (In Thousand People & %) (includescorresponding Graph/Chart) II-49
12. PRODUCT INTRODUCTIONS/INNOVATIONS II-50LifeScan Introduces New System for Testing Blood Glucose II-50Bayer Diabetes Care Launches Blood Glucose Meter II-50Bayer Introduces CONTOUR(R) USB II-50Roche Diagnostics Unveils Accu-Check Mobile Device in the UK II-51ARKRAY Unveils New Assure® Pro Blood Glucose Monitoring Strip II-51TRCL and Entra Health Systems Introduce AmCare Cell PhoneSupported Diabetes Management Services II-51Home Diagnostics Announces the US Launch of TRUE2go BloodGlucose Monitor II-52AgaMatrix Launches Kroger BGM II-52ARKRAY Obtains FDA Approval for GLUCOCARD® Vital BGM II-52Bayer Receives FDA Approval for Marketing CONTOUR USB II-52Medtronic Rolls Out Paradigm Veo II-53Home Diagnostics Introduces TRUEmanagerTM Diabetes ManagementSoftware II-53Fora Care to Introduce Affordable Diabetes Care Solutions II-54Roche Diagnostics Introduces Accu-Chek Smart Pix II-54Entra Launches MyGlucoHealth Meter in the US II-54ACON Unveils On Call® Plus Blood Glucose Monitoring System in US II-55
13. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVEBUILDER II-56Arkray and Piramal Introduce Advanced Glucocard 01 II-56BodyTel Scientific to Introduce GlucoTel System II-56Bio-Rad Launches Liquichek Diabetic Control II-57Home Diagnostics Introduces TRUEread II-57Medtronic's CGMS® iPro Receives FDA Approval II-57Siemens Introduces the DCA Vantage Analyzer II-57Arkray Introduces Analyzers for Diabetes Testing II-58Bayer Releases Brio® and Breeze® Diabetes Management Systemsin South Korea and China II-58GenExel-Sein Introduces DUO-CARE Home-Use Diabetes Products II-58HemoCue Unveils New Testing System for Point of Care Use II-58LifeScan Launches Easy-to-Use Glucose Meter II-58Roche Rolls Out ACCU-CHEK® Spirit Insulin Pump System II-59Novo Nordisk Introduces Simple-to Use GlucaGen® HypoKit II-59Biomerica Launches New Diabetes Diagnostic Test II-59Hypoguard Introduces New Glucose Meter II-60Bio-Rad Launches VARIANT II TURBO Monitoring System II-60Roche Launches Accu-Chek Go for Blood Glucose Monitoring II-60Roche Diagnostics Launches Accu-Chek Lancing System II-60LifeScan Introduces Glucose Meter in India II-60Abbott Laboratories Introduces Two New Glucose Meters in Europe II-60HDI Launches KetoCare Ketone Test Strips II-61Roche Diagnostics Unveils Accu-Chek D-TRON Plus II-61Abbott Introduces Precision Xtra Advanced Diabetes ManagementSystem II-61Abbott Diabetes Care Launches Precision Xtra Blood GlucoseTest Strip II-61LifeScan Introduces Onetouch Horizon II-61Bayer Diagnostics Unveils Ascensia® CONTOUR Blood GlucoseMonitoring System II-61
14. RECENT INDUSTRY ACTIVITY II-62Home Diagnostics and Nipro Diabetes to Merge to Form NiproDiagnostics II-62IVAX Diagnostics Inks Product Distribution Agreement withBiomerica II-62Terumo Spins-Off Diabetes Business II-62Premier Inks Alliance with Healthcare Companies II-62AgaMatrix and Sanofi-Aventis to Co-Develop Blood GlucoseMonitoring Solutions II-63Nippon Product Merges with Home Diagnostics II-63PositiveID Purchases Assets and Intellectual Property Rightsof Easy Check II-63Sanvita CBGM Acquires Assets of Sanvita II-63ARKRAY Secures FDA 510k Clearance for Assure® Platinum II-64Brazos Subsidiary to Merge with Epinex II-6415. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-65Neighborhood Diabetes Takes Over New York Diabetic Supply II-65Home Diagnostics Enters into an Exclusive Supply Deal withRite Aid Pharmacy Chain II-65OPG Acquires Hahn & Hahn II-65Nanobac Agrees to Acquire DNAPrint Genomics II-65Novo Nordisk's R&D Plans in India II-66Medco Health Solutions Announces Acquisition of PolyMedica II-66PolyMedica Takes over QualityCare II-66NationsHealth Acquires Diabetes Care & Education II-66Inverness Acquires Cholestech II-66WaveSense Launches European Subsidiary II-67XMDC, Diabetes Detection Sign on Distribution Agreement II-67IQMC Agrees on Acquisition of Lifecare AS II-67Bayer's Contour TS Test Strip Market Recall II-67BBI Acquires CDx and Audiometrics II-67Bayer Receives Ease-Of-Use Commendation for Ascensia® BREEZE®Blood Glucose Monitoring System II-68BYETTA® (exenatide) Receives Marketing Authorization fromEuropean Commission II-68Bayer Diabetes Care Acquires Metrika II-68BD Walks Out of BGM Market II-68Bio-Rad Acquires Provalis' Medical Diagnostics Division II-68Bio-Rad Inks Multi-Year Agreement with Premier II-69Cholestech and Life Line Collaborate Over Diagnostic Testing II-69FDA Approves Medtronic's MiniMed Paradigm® RT CGM System II-69FDA Clears Abbott's FreeStyle® Freedom Blood Glucose Meter II-69FDA Approves Hypoguard's Blood Glucose Monitor II-69FDA Approves DexCom's Continuous Glucose Monitoring System II-70Johnson & Johnson Acquires Animas Corporation II-70LifeScan and NIR Agree on Extension of First Option Agreement II-70Pfizer Obtains Global Rights to Inhalable Human Insulin -Exubera® II-70Roche Receives FDA Clearance for Acu-Check Insulin Pump II-70Sphere Medical and Analogic Team up for Monitoring Solutions II-71NeuroMetrix Wins Exclusive Marketing License of DigiScope II-71FDA Recommends Exubera® for Diabetic Patients II-71Bio-Rad and Sysmex Ink Co-Marketing Agreement II-71Diabetes Gold Forms Joint Venture with BioTex Labs II-71FDA Grants 510(k) Clearance for Abbott's Freestyle ConnectBlood Glucose Meter II-72FDA Clears Hypoguard's Advance Micro-draw Blood Glucose System II-72FDA Approves Home Diagnostics' Blood Glucose Testing System II-72Insulet Corporation and Solectron Collaborate to Develop OmniPod II-72PolyMedica Acquires National Diabetic Pharmacies II-73Cygnus, Inc. Divests its Glucose-Monitoring Assets II-73Home Diagnostics' Blood Glucose Monitor Features in Best RxValue Drug List of Ohio II-73Roche Diagnostics Receives US FDA Approval for its LatestBlood Glucose Meter II-73Provalis Ships in2it A1C to US II-73Hitachi Develops Unique Non-Invasive Device for DiabetesMonitoring II-73Bayer Diagnostics Business Splits into Two Units II-74Abbott Laboratories Acquires TheraSense Inc. II-74Roche Acquires Infusion Systems Division of Disetronic II-74Bristol-Myers Squibb Enters into Alliance with Merck II-74Provalis Receives FDA Approval II-74Gunze Enters into an Agreement with Sanko Junyaku Strike II-75Health Hero Network Receives US FDA Approval II-75Roche Diagnostics Corporation Receives Contract from Premier Inc II-75Vitro Introduces Stem Cell Therapy for Diabetes II-75Home Diagnostics' Blood Glucose Monitor Features in RxAmericaNational Formulary II-75Home Diagnostics' Blood Glucose Monitor Features in Procare RxNational Formulary II-75Medtronic Receives FDA Approval for its New Continuous GlucoseMonitoring System II-76Roche Diagnostics Awarded Blood Glucose and Lancet Contracts II-76HDI's TrueTrack Smart System Wins FDA Approval for AST II-76Seradyn Bags US FDA Clearance for HbA1c Assay II-76Bristol-Myers Squibb Receives Exclusive Rights to AlcNowDiabetes Monitor II-77Bio-Rad Laboratories Awarded 510(k) Clearance for VARIANT IITURBO II-77
16. FOCUS ON SELECT GLOBAL PLAYERS II-78Abbott Diabetes Care (US) II-78Bayer Diabetes Care (US) II-78Bio-Rad Laboratories (US) II-78Nipro Diagnostics, Inc. (US) II-79LifeScan, Inc. (US) II-79Medtronic MiniMed, Inc. (US) II-79Roche Diagnostics (Switzerland) II-80Sanwa Kagaku Kenkyusho Co, Ltd. (Japan) II-80Siemens Healthcare Diagnostics (US) II-80
17. GLOBAL MARKET PERSPECTIVE II-82Table 11: World Recent Past, Current & Future Analysis forDiabetes Diagnostics by Geographic Region/Country - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-82Table 12: World Historic Review for Diabetes Diagnostics byGeographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-83Table 13: World 15-Year Perspective for Diabetes Diagnosticsby Geographic Region - Percentage Breakdown of Dollar Salesfor US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) II-84Table 14: World Recent Past, Current & Future Analysis forBlood Glucose Testing Devices by Geographic Region/Country -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2009through 2017 (includes corresponding Graph/Chart) II-85Table 15: World Historic Review for Blood Glucose TestingDevices by Geographic Region/ Country - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-86Table 16: World 15-Year Perspective for Blood Glucose TestingDevices by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets for Years2003, 2011 & 2017 (includes corresponding Graph/Chart) II-87Table 17: World Recent Past, Current & Future Analysis forBlood Glucose Testing Devices by Product Segment - BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2009through 2017 (includes corresponding Graph/Chart) II-88Table 18: World Historic Review for Blood Glucose TestingDevices by Product Segment - Blood Glucose Test Kit, BloodGlucose Meter/Monitor, Diabetes Kit, and Diabetes TrackingSystem Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-89Table 19: World 15-Year Perspective for Blood Glucose TestingDevices by Product Segment - Percentage Breakdown of DollarSales for Blood Glucose Test Kit, Blood Glucose Meter/Monitor,Diabetes Kit, and Diabetes Tracking System Markets for Years2003, 2011, & 2017 (includes corresponding Graph/Chart) II-90Table 20: World Recent Past, Current & Future Analysis forBlood Glucose Test Kits by Geographic Region/Country - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-91Table 21: World Historic Review for Blood Glucose Test Kits byGeographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-92Table 22: World 15-Year Perspective for Blood Glucose TestKits by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets for Years2003, 2011 & 2017 (includes corresponding Graph/Chart) II-93Table 23: World Recent Past, Current & Future Analysis forBlood Glucose Meters/Monitors by Geographic Region/ Country -US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2009through 2017 (includes corresponding Graph/Chart) II-94Table 24: World Historic Review for Blood Glucose Meters/Monitors by Geographic Region/ Country - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-95Table 25: World 15-Year Perspective for Blood GlucoseMeters/Monitors by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-96Table 26: World Recent Past, Current & Future Analysis forDiabetes Kits by Geographic Region/Country - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart) II-97Table 27: World Historic Review for Diabetes Kits byGeographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-98Table 28: World 15-Year Perspective for Diabetes Kits byGeographic Region - Percentage Breakdown of Dollar Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) II-99Table 29: World Recent Past, Current & Future Analysis forDiabetes Tracking Systems by Geographic Region/Country - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-100Table 30: World Historic Review for Diabetes Tracking Systemsby Geographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-101Table 31: World 15-Year Perspective for Diabetes TrackingSystems by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets for Years2003, 2011 & 2017 (includes corresponding Graph/Chart) II-102Table 32: World Recent Past, Current & Future Analysis forDiabetes Testing Supplies by Geographic Region/Country - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-103Table 33: World Historic Review for Diabetes Testing Suppliesby Geographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-104Table 34: World 15-Year Perspective for Diabetes TestingSupplies by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets for Years2003, 2011 & 2017 (includes corresponding Graph/Chart) II-105Table 35: World Recent Past, Current & Future Analysis forDiabetes Testing Supplies by Product Segment - Blood GlucoseTest Strips, Lancet, Lancet Device, and Reagent Strip MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) II-106Table 36: World Historic Review for Diabetes Testing Suppliesby Product Segment - Blood Glucose Test Strips, Lancet, LancetDevice, and Reagent Strip Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003 through2008 (includes corresponding Graph/Chart) II-107Table 37: World 15-Year Perspective for Diabetes TestingSupplies by Product Segment - Percentage Breakdown of DollarSales for Blood Glucose Test Strips, Lancet, Lancet Device,and Reagent Strip Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) II-108Table 38: World Recent Past, Current & Future Analysis forBlood Glucose Test Strips by Geographic Region/Country - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-109Table 39: World Historic Review for Blood Glucose Test Stripsby Geographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-110Table 40: World 15-Year Perspective for Blood Glucose TestStrips by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets for Years2003, 2011 & 2017 (includes corresponding Graph/Chart) II-111Table 41: World Recent Past, Current & Future Analysis forLancets by Geographic Region/ Country - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) II-112Table 42: World Historic Review for Lancets by GeographicRegion/Country - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) II-113Table 43: World 15-Year Perspective for Lancets by GeographicRegion - Percentage Breakdown of Dollar Sales for US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) II-114Table 44: World Recent Past, Current & Future Analysis forLancet Devices by Geographic Region/Country - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart) II-115Table 45: World Historic Review for Lancet Devices byGeographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-116Table 46: World 15-Year Perspective for Lancet Devices byGeographic Region - Percentage Breakdown of Dollar Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) II-117Table 47: World Recent Past, Current & Future Analysis forReagent Strips by Geographic Region/Country - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart) II-118Table 48: World Historic Review for Reagent Strips byGeographic Region/Country - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008 (includescorresponding Graph/Chart) II-119Table 49: World 15-Year Perspective for Reagent Strips byGeographic Region - Percentage Breakdown of Dollar Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) II-120Table 50: World Recent Past, Current & Future Analysis forOther Diabetes Diagnostic Products/Supplies by GeographicRegion/Country - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) II-121Table 51: World Historic Review for Other Diabetes DiagnosticProducts/Supplies by Geographic Region/ Country - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2003 through 2008(includes corresponding Graph/Chart) II-122Table 52: World 15-Year Perspective for Other DiabetesDiagnostic Products/Supplies by Geographic Region - PercentageBreakdown of Dollar Sales for US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets for Years 2003, 2011 & 2017 (includescorresponding Graph/Chart) II-123
III. MARKET
1. THE UNITED STATES III-1A.Market Analysis III-1Glucose Monitoring Market Bounces Back, Post Recession III-1Competitive Landscape III-1Table 53: US Blood Glucose Monitoring Market (2011) :Percentage Share Breakdown for Leading Brands (includescorresponding Graph/Chart) III-1Diabetes Prevalence in the US by Type III-2Table 54: Diabetes Prevalence in the US by Type: 2008(includes corresponding Graph/Chart) III-2Diabetes: A Leading Cause of Death in the US III-2Market Trends III-3Companies Focus on Research for Better Diabetes Diagnostics III-3Focus on Established Procedures Driving Growth III-3Insulin Delivery Systems - A Potential High Growth Segment III-3Competitive Landscape III-4Roche Losing its Share in the US Blood Glucose MonitorsMarket III-4B.Market Analytics III-5Table 55: The US Recent Past, Current & Future Analysis forDiabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) III-5Table 56: The US Historic Review for Diabetes Diagnostics byProduct Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003 through2008 (includes corresponding Graph/Chart) III-6Table 57: The US 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-7
2. CANADA III-8A.Market Analysis III-8Diabetes Incidence III-8B.Market Analytics III-9Table 58: Canadian Recent Past, Current & Future Analysisfor Diabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-9Table 59: Canadian Historic Review for Diabetes Diagnosticsby Product Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/ Monitor, DiabetesKit, and Diabetes Tracking System) and Diabetes TestingSupplies (Blood Glucose Test Strips, Lancet, Lancet Device,And Reagent Strip) and Other Markets Independently Analyzedwith Annual Sales Figures in US$ Thousand for Years 2003through 2008 (includes corresponding Graph/Chart) III-10Table 60: Canadian 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) And Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-11
3. JAPAN III-12A.Market Analysis III-12Growing Aging Population Drives Diabetes Diagnostics Market III-12Other Trends Influence Diabetes Diagnostics Market III-12B.Market Analytics III-13Table 61: Japanese Recent Past, Current & Future Analysisfor Diabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-13Table 62: Japanese Historic Review for Diabetes Diagnosticsby Product Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Thousand for Years 2003 through2008 (includes corresponding Graph/Chart) III-14Table 63: Japanese 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-15
4. EUROPE III-16A.Market Analysis III-16Significant Increase in the Number of Diabetics III-16B.Market Analytics III-17Table 64: European Recent Past, Current & Future Analysisfor Diabetes Diagnostics by Geographic Region/Country -France, Germany, Italy, UK and Rest of Europe MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) III-17Table 65: European Historic Review for Diabetes Diagnosticsby Geographic Region/Country - France, Germany, Italy, UKand Rest of Europe Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003 through2008 (includes corresponding Graph/Chart) III-18Table 66: European 15-Year Perspective for DiabetesDiagnostics by Geographic Region/Country - PercentageBreakdown of Dollar Sales for France, Germany, Italy, UK andRest of Europe Markets for Years 2003, 2011 & 2017 (includescorresponding Graph/Chart) III-19Table 67: European Recent Past, Current & Future Analysisfor Diabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) III-20Table 68: European Historic Review for Diabetes Diagnosticsby Product Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003 through2008 (includes corresponding Graph/Chart) III-21Table 69: European 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-22
4a. FRANCE III-23Market Analytics III-23Table 70: French Recent Past, Current & Future Analysis forDiabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, And Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-23Table 71: French Historic Review for Diabetes Diagnostics byProduct Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) Glucose Insta Glucose) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2003 through 2008 (includes correspondingGraph/Chart) III-24Table 72: French 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-25
4b. GERMANY III-26Market Analytics III-26Table 73: German Recent Past, Current & Future Analysis forDiabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-26Table 74: German Historic Review for Diabetes Diagnostics byProduct Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Thousand for Years 2003 through2008 (includes corresponding Graph/Chart) III-27Table 75: German 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-28
4c. ITALY III-29Market Analytics III-29Table 76: Italian Recent Past, Current & Future Analysis forDiabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-29Table 77: Italian Historic Review for Diabetes Diagnosticsby Product Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Thousand for Years 2003 through2008 (includes corresponding Graph/Chart) III-30Table 78: Italian 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-31
4d. THE UNITED KINGDOM III-32Market Analytics III-32Table 79: UK Recent Past, Current & Future Analysis forDiabetes Diagnostics by Product Segment - Blood GlucoseTesting Devices (Blood Glucose Test Kit, Blood GlucoseMeter/Monitor, Diabetes Kit, and Diabetes Tracking System)and Diabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2009 through 2017 (includes correspondingGraph/Chart) III-32Table 80: UK Historic Review for Diabetes Diagnostics byProduct Segment - Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,and Diabetes Tracking System) and Diabetes Testing Supplies(Blood Glucose Test Strips, Lancet, Lancet Device, andReagent Strip) and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Thousand for Years 2003 through2008 (includes corresponding Graph/Chart) III-33Table 81: UK 15-Year Perspective for Diabetes Diagnostics byProduct Segment - Percentage Breakdown of Dollar Sales forBlood Glucose Testing Devices (Blood Glucose Test Kit, BloodGlucose Meter/Monitor, Diabetes Kit, and Diabetes TrackingSystem) and Diabetes Testing Supplies (Blood Glucose TestStrips, Lancet, Lancet Device, and Reagent Strip) and OtherMarkets for Years 2003, 2011 & 2017 (includes correspondingGraph/Chart) III-34
4e. REST OF EUROPE III-35Market Analytics III-35Table 82: Rest of European Recent Past, Current & FutureAnalysis for Diabetes Diagnostics by Product Segment - BloodGlucose Testing Devices (Blood Glucose Test Kit, BloodGlucose Meter/Monitor, Diabetes Kit, and Diabetes TrackingSystem) and Diabetes Testing Supplies (Blood Glucose TestStrips, Lancet, Lancet Device, and Reagent Strip) and OtherMarkets Independently Analyzed with Annual Sales Figures inUS$ Thousand for Years 2009 through 2017 (includescorresponding Graph/Chart) III-35Table 83: Rest of European Historic Review for DiabetesDiagnostics by Product Segment - Blood Glucose TestingDevices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) andDiabetes Testing Supplies (Blood Glucose Test Strips,Lancet, Lancet Device, and Reagent Strip) and Other MarketsIndependently Analyzed with Annual Sales Figures in US$Thousand for Years 2003 through 2008 (includes correspondingGraph/Chart) III-36Table 84: Rest of European 15-Year Perspective for DiabetesDiagnostics by Product Segment - Percentage Breakdown ofDollar Sales for Blood Glucose Testing Devices (BloodGlucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
To order this report:In Vitro Diagnostic Industry: Global Diabetes Diagnostics Industry
More Market Research Report
Check our Industry Analysis and Insights
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
